Document is current
Any future updates will be listed below
-
Authors
Lee, Seung Soo
Oudjedi, Fatma
Kirk, Andrew G.
Paliouras, Miltiadis
Trifiro, Mark A.
-
Funding
Funding for this research was provided by:
Ministère de l'Économie, de la Science et de l'Innovation - Québec (17-19-PSVTB-41293, 17-19-PSVTB-41293, 17-19-PSVTB-41293)
- License Information
-
More Information
Article History
Received: 26 August 2022
Accepted: 28 March 2023
First Online: 5 April 2023
Declarations
:
: Animal ethics approval for this project was provided by McGill University Animal Compliance Office (2014-7463). All individuals that handled the animals received certified training.
: Not applicable.
: MP and MAT are inventors of the following patent application, (WO2015070351), Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent. MP and MAT are minority shareholders in Guzzo Nano Research Corp. (GNR). GNR has obtained a license agreement from McGill University to commercially develop the technology.
